Companies: 10,795·Total market cap: $144.5T
Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc.

INBXNASDAQHealthcare● Active
$88.93
+$1.92(+2.21%)
Market Cap$1.3B
P/E Ratio
52W High$155.29
52W Low$12.8
Overview

Inhibrx Biosciences, Inc.(INBX)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

inbx · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
2
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 60.0%

12 个月目标价

High

$325

Consensus

$325

+264.3% upside

Low

$325

Median: $325 · Last Close: $89.21

Inhibrx Biosciences, Inc.(INBX)的分析师共识为 Buy,基于过去 3 个月内 5 位华尔街分析师的评级。INBX 的 12 个月平均目标价为 $325.00,相对当前价 $89.21 代表 +264.3% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$84.755.00%

1-day model range: $83.86–$85.63. Peak: $85.63 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%22%71%
1Buy
3Neutral
10Sell
RSI (14)32.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · INBX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$91.26SELL
MA 10$97.34SELL
MA 20$104.48SELL
MA 50$99.96SELL
MA 100$87.36BUY
MA 200$0.00NEUTRAL
Current $INBX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$91.72SELL
EMA 10$96.24SELL
EMA 20$101.56SELL
EMA 50$99.61SELL
EMA 100$93.01SELL
EMA 200$0.00NEUTRAL
Current $INBX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
JMP Securities2025-08-22
Maintains
Market PerformMarket Perform
JMP Securities2025-05-15
Maintains
Market PerformMarket Perform
Citizens Capital Markets2025-03-18
Maintains
Market PerformMarket Perform
JMP Securities2025-01-22
Maintains
Market PerformMarket Perform
JMP Securities2024-01-23
Downgrade ↓
Market OutperformMarket Perform
JMP Securities2023-11-20
Maintains
Market OutperformMarket Outperform
JMP Securities2023-08-23
Maintains
OutperformOutperform
JMP Securities2023-05-10
Maintains
Market OutperformOutperform
JMP Securities2023-03-08
Maintains
Market OutperformMarket Outperform
Credit Suisse2023-03-07
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Inhibrx Biosciences, Inc. (INBX) stock. Of the recent 19 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover INBX.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

INBX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$4M

↓ 96.7% YoY

Revenue Next Year

$57M

↑ 1230.2% YoY

EPS This Year

$-9.23

EPS Next Year

$-6.53

↓ 29.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast INBX EPS of $-9.23 for the current fiscal year, based on estimates from 1 analysts. The INBX revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

INBX 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。INBX 的共识目标价为 $325.00(+264.3% 上行空间),分析师共识为 Buy。

INBX 的短期预测(明日)为 $84.75(-5.00%)。

Inhibrx Biosciences, Inc. 在 NASDAQ 上市,代码 INBX。INBX 在 2027 年的整体展望偏积极,在覆盖分析师中约 60% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

INBX 预测 · 8 个问题

根据 5 位华尔街分析师,INBX 的 12 个月平均目标价为 $325.00,最高 $325.00、最低 $325.00。若有图表,中位目标价可在上方查看。相对当前价 $89.21,隐含约 +264.3% 的上行空间。

INBX 目标价INBX 分析师目标价INBX 12个月目标价目标价 INBX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.